General Anaesthetics Flashcards

1
Q

Uses of GA:

A
  • Produce unconsciousness and lack of responsiveness to all painful stimuli – inhibit sensory and autonomic reflexes
  • causes hypnosis, amnesia and analgesia
  • allow for skeletal muscle relaxation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GA stages:

A
  1. Pre-assessment/premed
  2. Induction of anaesthesia
  3. Airway management
  4. Maintenance of anaesthesia
  5. Reversal/emergency
  6. Post-operative care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Traits of ideal GA:

A
  • Unconsciousness
  • Analgesia
  • Muscle relaxation
  • Amnesia
  • Brief and pleasant
  • Depth of anesthesia can be increased or decreased with ease
  • Minimal adverse effects
  • Large margin of safety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drugs commonly used in combination in GA:

A
  • inhalation and intravenous anaesthetics
  • Short-acting barbiturates (induction)
  • NM blocking agents (muscle relaxation)
  • Opioids and nitrous oxide (analgesia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is MAC:

A

index of inhalation anaesthetic potency (the lower the MAC, the more potent it is)

  • Defined as minimum concentration of drug in alveolar air that will produce immobility in 50% of patients exposed to painful stimulus
  • Values alter with age, condition, concommitant administration of other drugs etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Examples of inhalation anaesthetics:

A

volatile liquids: halothane, enflurane, desflurane, isoflurane, sevoflurane
Gases: nitrous oxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Possible MoA of Inhaled GA:

A
  1. enhance neurotransmission at inhibitory synapses via allosterically increasing GABA receptor sensitivity to action by GABA itself (positive allosteric modulator)
  2. Depress neurotrransmission at excitatory synapses via blocking glutamate neurotransmitter acting on NMDA receptor – prevent activation (negative allosteric modulator)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors affecting absorption of Inhaled GA:

A
  1. Concentration of anaesthetic in inspired air
  2. Solubility of GA in blood
  3. Blood flow through lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factor affecting distribution of inhaled GA:

A

Regional blood flow – determines which tissues receive GA – highly perfused tissues will have the anaesthetic levels equilibrating with those in blood quickly after administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mechanism of elimination of inhalation anaesthetics:

A

exported in expired breath
eliminated almost entirely via lungs
minimal hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metabolites of inhalation anaesthetics

A
  • Inorganic fluorides(isoflurane and enflurane) – nephrotoxic
  • Halothane – hepatotoxic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adverse effects of halothane:

A
  • Respiratory depression (dose-dependent)
  • decreased BP due to depression of cardiac output
  • Arrhythmia
  • halothane-associated hepatitis
  • (May be a use as well) relaxes skeletal muscle and potentiates skeletal muscle relaxants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adverse effects of isoflurane:

A
  • dose-dependent respiratory depression
  • decreased BP due to decrease in systemic/vascular resistance
  • less hypotension and arrhythmia compared to halothane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MAC of inhaled anaesthetics:

A

Halothane: 0.75%
Isoflurane: 1.4%
Sevoflurane: 2%
Nitrous oxide: 105-110%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mechanism of nephrotoxicity in sevoflurane:

A

metabolised in liver to release inorganic fluoride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rank the time needed for onset and recovery of inahled anaesthetics:

  • Isoflurane
  • Halthane
  • Nitrous Oxide
  • Sevoflurane
A

nitrous oxide < sevoflurane < isoflurane and halothane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

limitations of use of nitrous oxide in GA: :

A

give analgesia and amnesia but not complete unconsciousness/surgical anaesthesia
- used to supplement analgesic effects of primary anaesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Major concern in use of nitrous oxide

A

post-operative nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Things to take note of in the use of sevoflurane:

A

degrade to compound that is potentially nephrotoxic when exposed to carbon dioxide absorbants in anaesthetic machines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Types of intravenous anaesthetics

A

thiopentane, etomidate, propofol, ketamine, midazolam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Purpose of IV anaesthetics. Comment on its duration of action

A
  • induce unconsciousness

- does not keep you asleep for very long – effects on its own is not very long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Advantages of using a combination of inh and iv anaesthetics:

A
  1. permit dosage of inhalation agent to be decreased

2. produce effects that cannot be achieved with an inhalation GA alone

23
Q

advantage of thiopentone:

A

extremely high lipid solubility – enters brain easily and rapidly for rapid onset of action – unconsciousness occurs 10-20 sec after IV

24
Q

pk of thiopentone:

A
  • Large Volume of Distribution
  • Active metabolite Pentobarbital – liver cirrhosis can result in prolongation of clinical action
  • Extensively bound to plasma proteins – small amount of free drug excreted by glomerular filtration + reabsorption in tubules
  • Less than 1% excreted unchanged
25
Q

MoA of thiopentone:

A

Cause CNS depression by potentiating action of GABA on GABA-A receptor-gated chloride ion channels

  • Does not replace neurotransmitter but allow for more effective binding
  • lead to greater entry of chloride ions as channel is open, making it difficult to depolarise
26
Q

What is Propofol used for in patients who require anaesthesia?

A

For both induction and maintenance (by infusion)

27
Q

Onset and duration of propofol:

A
rapid onset ( unconsciousness develops within ~60 sec) 
short duration of action (~3-5 min following single injection) 
rapid distribution from brain to other tissues
28
Q

use of propofol:

A

extensively used in day surgeries, need continuous, low dose infusion for extended effects

29
Q

benefits of using propofol over using other anaesthetic agents

A
  • reduced postoperative vomiting (anti-emetic action)
30
Q

side effects of propofol:

A

significant CV effects during induction: lowered BP and negative inotropic –> hypotension

31
Q

caution for use of propofol:

A

used with caution in elderly patients, patients with compromised cardiac function, hypovolemic patients

32
Q

what makes ketamine different from other IV anaesthetic

A
  • only IV anaesthetic possessing analgesic property
  • produce state of dissociative anaesthesia – patient dissociated from environment, commonly used in vet practice/antidepressant with fast onset
33
Q

Effects of ketamine:

A

Sedation, immobility, analgesia, amnesia

34
Q

PK of ketamine:

A
  • metabolised in liver to less active metabolite, excreted in bile
  • Large volume of distribution, rapid clearance – suitable for continuous infusion without lengthening duration of action
35
Q

benefits of using ketamine:

A

rapid induction, responsiveness to pain is lost – good analgesic effects

36
Q

Adverse effects of ketamine:

A

unpleasant psychologic reactions (hallucination, disturbing dreams, delirium) may occur during recovery

37
Q

Methods to reduce adverse effects of ketamine:

A

premedication of diazepam/midazolam

38
Q

Types of anaesthetic adjuncts:

A
  1. Benzodiazepines (IV midazolam)
  2. a2 adrenergic agonists (IV dexmedetomidine)
  3. Analgesics (NSAIDs/Opioids)
  4. Neuromuscular blockers (succinylcholine, vecuronium)
39
Q

use of BZDs as anaesthetic adjuncts:

A

used for sedation during procedures not requiring GA

as anxiolytics, for amnesia and sedation prior to induction of anaesthesia

40
Q

benefits of using BZDs as anaesthetic adjuncts:

A
  • rapid onset when used for induction (unconsciousness develops in 80 seconds)
  • High therapeutic index
41
Q

metabolism of IV midazolam:

A

metabolised in liver – people with liver issues will be more sensitive

42
Q

adverse effects of IV midazolam:

A

CV and respiratory depressing effect (less compared to other IV anaesthetics) – compounded by use with other agents

43
Q

how to mitigate adverse effects of IV midazolam:

A

inject midazolam slowly (2 or more mins) and wait another 2 more mins for full effects before dosing again – side effects minimised by dragging out administration duration

44
Q

how is IV dexmedetomidine used in GA:

A
  • sedation prior to and/or during procedures in non-intubated patients
  • short-term sedation (<24 hours)
45
Q

benefits in use of IV dexmedetomidine:

A
  • little respiratory depression
  • has sedative and analgesic effects
  • Tolerable decrease in bp and HR
46
Q

Side effects of IV dexmedetomidine:

A

nausea, dry mouth, hypotension, bradycardia

47
Q

list of possible analgesics that can be used during/post operation:

A
fentanyl
morphine
sufentanil
remifentanil 
alfentanil
48
Q

Why and when are analgesics used with GA:

A
  • to decrease anaesthetic requirement

- for minor surgical procedures (cox-2 inhibitors, paracetamol and opioids for perioperative period)

49
Q

Metabolism and excretion of analgesics:

A

metabolised in liver (remifentanil hydrolysed by tissue and plasma esterases)
excretion in urine and bile

50
Q

Use of NM blockers in GA:

A

used during induction of anaesthesia to relax muscles to facilitate laryngoscopy and endotracheal intubation
- aids many surgical procedures and provide additional insurance of immobility

51
Q

two NM blockers commonly used:

A

depolarising: succinylcholine

non-depolarising: vecuronium

52
Q

caution when using IV NM blockers:

A

barbiturates will precipitate when mixed with muscle relaxants – should be allowed to clear from IV line

53
Q

Reason for ultra-short duration of action of thiopentone

A

redistributes to less vascularised tissues